• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Hikma Pharmaceuticals PLC (HIK)

ORD SHS 10P
Sell: 1,611.00p|Buy: 1,613.00p|Change: 5.00 (0.31%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Company profile

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority ofthe company's revenue is generated from its injectables segment, which supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue-generating market, followed by the Middle East and North Africa, the United Kingdom, Europe, and the rest of the world.

Address


London
GBR
W1S 2HR

Telephone

+44 2073992760

Website

https://www.hikma.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Hikma Pharmaceuticals PLC Second Quarter Earnings Results for 20272027-08-06T00:00:00
Hikma Pharmaceuticals PLC Annual General Meeting for 20262027-04-23T10:00:00
Hikma Pharmaceuticals PLC Annual Report for 20262027-03-18T00:00:00
Hikma Pharmaceuticals PLC Fourth Quarter Earnings Conference Call for 20262027-02-26T09:30:00
Hikma Pharmaceuticals PLC Fourth Quarter Earnings Results for 20262027-02-26T00:00:00

Previous key dates

NameKey Date
Hikma Pharmaceuticals PLC Second Quarter Earnings Results for 20262026-08-06T00:00:00
Hikma Pharmaceuticals PLC Annual General Meeting for 20252026-04-23T10:00:00
Hikma April 2026 Trading Update2026-04-23T08:30:00
Hikma Pharmaceuticals PLC Annual Report for 20252026-03-18T00:00:00
Hikma Pharmaceuticals PLC Fourth Quarter Earnings Conference Call for 20252026-02-26T09:30:00
Hikma Pharmaceuticals PLC Fourth Quarter Earnings Result for 20252026-02-26T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.